Praxbind復安凝

Praxbind

idarucizumab

Manufacturer:

Boehringer Ingelheim

Distributor:

Zuellig
/
Agencia Lei Va Hong
Concise Prescribing Info
Contents
Idarucizumab
Indications/Uses
Rapid reversal of the anticoagulant effects of dabigatran in adult patients during emergency surgery/urgent procedure & in life-threatening or uncontrolled bleeding.
Dosage/Direction for Use
IV 5 g (2 x 2.5 g/50 mL) as 2 consecutive infusions over 5-10 min each or as bolus inj.
Special Precautions
Discontinue use if anaphylactic reaction or other serious allergic reaction occurs. May expose patients to thrombotic risk due to underlying disease. Risk of transient proteinuria. Hereditary fructose intolerance. Patients on controlled Na diet.
ATC Classification
V03AB37 - idarucizumab ; Belongs to the class of antidotes. Used to reverse anticoagulant effects of dabigatran.
Presentation/Packing
Form
Praxbind soln for inj/infusion 2.5 g/50 mL
Packing/Price
2 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in